Latest diabetes mellitus Stories

PORTLAND, Ore., Jan. 28, 2013 /PRNewswire/ -- For people with diabetes, meeting the recommended guidelines for blood pressure and cholesterol is even more important than meeting the guidelines for blood-sugar control in reducing the risk of heart attack or stroke, according to a new Kaiser Permanente study published today in the Journal of General Internal Medicine. The study included more than 26,000 patients with diabetes. Patients who met guidelines for all three risk...

NEW ORLEANS, Jan. 28, 2013 /PRNewswire/ -- Pamlab L.L.C., developer and marketer of Metanx(®), announced today that a multicenter study, done in collaboration with Tulane University, was published in The American Journal of Medicine. The study suggests that nutritional management of diabetic peripheral neuropathy (DPN) with L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate, a prescription medical food dispensed by prescription and commercially known as Metanx(®),...

For 10+ years Extend Nutrition™ has been a leading nutritional snack Company with the only product line, developed by a world-renowned doctor, clinically proven to reduce the calories consumed at the next meal by an average of 21%. Saint Louis, MO (PRWEB) January 24, 2013 Trying a new weight loss plan can feel overwhelming. There is a plethora of contradictory health and nutrition information available – making it nearly impossible to make healthy decisions. Extend Nutrition takes the...

KALAMAZOO, Mich., Jan. 24, 2013 /PRNewswire/ -- Metabolic Solutions Development Company, LLC (MSDC) announced today the publication of data from a Phase 2b study of the company's prototype insulin sensitizer in patients diagnosed with type 2 diabetes. The data demonstrate MSDC-0160, a novel once-a-day oral insulin sensitizer and the first in a new class of therapeutic agents called mTOT Modulators(TM), met the study's primary endpoint of significantly reducing fasting plasma glucose...

OTTAWA, Jan. 24, 2013 /CNW/ - Health Canada is informing Canadians of a labelling update for all cholesterol-lowering drugs (also known as statins) regarding the risk of increased blood sugar levels and a small increased risk of diabetes among patients already at risk for the disease. Based on the review of all available data, Health Canada concluded that the risk of diabetes appears to be mainly in patients with pre-existing risk factors for diabetes, such as high levels of...

Over the past two decades, the incidence of type 1 diabetes in very young children under age 5 has increased by 70 percent in the city of Philadelphia, according to research from a University of Pennsylvania School of Nursing researcher who currently maintains the only US registry of diabetes in children that has collected data continuously since 1985. In a far-reaching study published online today in Diabetes Care, researchers led by nursing professor Terri H. Lipman, PhD, RN found that...

CALGARY, Alberta, Jan. 22, 2013 /PRNewswire/ -- Fero Industries, Inc. (OTC: FROI), the exclusive producer, marketer & distributor of Sucanon®, an oral type-2 Diabetes treatment, announced today that the company has hired Barry Hall, through his consulting company Carlaris LV Inc., as Interim CFO. Mr. Hall is the former CFO of EarthLink and brings extensive experience in accounting, corporate governance and strategic planning to the company. "Barry's high level of experience is...

PRINCETON, N.J., Jan. 22, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today kicked off the first NovoLog(®) Community Star contest. As part of the program, type 2 diabetes patients successfully managing their blood sugar with NovoLog(®) (insulin aspart [rDNA origin] injection) are invited to visit www.novolog.com and tell us how they're giving back to their local communities. To view the multimedia assets associated with this release, please click:...

WASHINGTON, Jan. 22, 2013 /PRNewswire/ -- Voxiva, Inc. announces the launch of the latest version of its diabetes self-management program, care4life(SM), which now includes content from select American Diabetes Association publications. Developed by Voxiva, the company behind text4baby(SM), the nation's largest mobile health initiative, care4life is a mobile-based interactive diabetes education and support service that incorporates text messaging, a personal online web portal and a...

This study is a Phase 1, Placebo-Controlled, Randomized Trial to Assess the Safety and Tolerability of a New Drug in Obese Hyperlipidemic Adults with or without Type 2 Diabetes DeLand, Florida (PRWEB) January 21, 2013 **Avail Clinical Research is now enrolling for a Type 2 Diabetes Clinical Trial in Florida. To get started, visit Avail Clinical Research or call us directly at (386) 310-1334. BACKGROUND & RATIONALE Type 2 diabetes (T2DM) is one of the largest medical burdens in the...